SCHOTT and Hungarian government invest in cutting-edge syringe production
A €76 million investment at SCHOTT’s existing site in Lukácsháza, Hungary is designed to meet the growing global demand for prefillable syringes made of glass.
The company is planning to build an entirely new production line for high-quality prefillable glass syringes (PFS).
“The added capacity will greatly benefit the global market and strengthen supply security for major pharmaceutical companies and contract manufacturing organizations,” said Andreas Reisse, Executive Vice President of SCHOTT’s Pharma business unit.
The double-digit million Euro amount is supported by the local government with about €9 million.
The expansion is scheduled for completion in 2024 and is designed to create 120 new jobs.
Image: SCHOTT’s prefillable syringes made of glass store vaccines and biologics.
